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Abstract Monitoring of continuous blood pressure and
cardiac output is important to prevent hypoperfusion and to
guide fluid administration, but only few patients receive
such monitoring due to the invasive nature of most of the
methods presently available. Noninvasive blood pressure
can be determined continuously using finger cuff technol-
ogy and cardiac output is easily obtained using a pulse
contour method. In this way completely noninvasive con-
tinuous blood pressure and cardiac output are available for
clinical use in all patients that would otherwise not be
monitored. Developments and state of art in hemodynamic
monitoring are reviewed here, with a focus on noninvasive
continuous hemodynamic monitoring form the finger.
Keywords Blood pressure  Cardiac output  Finapres
methodology  Nexfin  CO-trek  Pulse contour analysis
1 Introduction
The primary evaluation of the hemodynamic condition is
done by assessing heart rate (HR) and mean blood pressure
(BP) as a surrogate of tissue perfusion. When these
parameters change rapidly, a single measurement conveys
insufficient information, making continuous measurement
desirable [1]. For continuous measurement of BP, cannu-
lation of an artery is the primary approach. However,
noninvasive and continuous monitoring of BP has several
advantages, particularly if intra-arterial measurement of BP
is not warranted while intermittent measurements do not
have the required time resolution [2]. Finger cuff tech-
nology can provide such continuous and noninvasive
monitoring of BP and other hemodynamics parameters.
Although giving vital information, BP and HR due to
their regulated nature frequently do not respond to sub-
stantial changes in intravascular volume, e.g. fluid admin-
istration or blood loss. Age and pre-existing cardiovascular
morbidity complicate interpretation of these parameters
further [3–9]. In supine adults hypotension and tachycardia
are frequently absent even after blood loss of more than 1 l
[3–8, 10, 11]. Therefore, fluid administration to optimize
cardiac preload guided by BP is not straightforward. In
contrast, cardiac output (CO) and especially cardiac stroke
volume (SV) are sensitive to deviations in preload [7, 8].
Also, when arterial pressure is being restored by adminis-
tering sympathomimetic drugs, it is at the expense of
regional flow possibly including that to the brain [12].
Moreover, there is growing evidence that a patient’s
cumulative fluid balance as well as strategy to guide fluid
administration have an impact on patient morbidity and
hospital stay. This has stimulated the development of
methods that immediately detect changes in cardiac preload
and output. With techniques like trans-esophageal and
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thoracic echocardiography or Doppler [13, 14], arterial
pulse contour analysis [15–18] and determination of CO by
lithium kinetics [19], several alternatives to the traditional
indicator dilution and pulmonary artery catheterization
techniques [20–22] have become available. These alterna-
tives facilitate continuous and even noninvasive evaluation
of volume treatment of patients [23]. Many continuous CO
monitoring devices are called ‘‘minimally invasive’’ since
they use arterial access that is already present for moni-
toring of BP or blood gas analysis. Nonetheless, the use of
these devices is restricted to patients having such access.
Recently, several completely noninvasive devices measur-
ing continuous BP or CO were introduced for clinical use.
The Nexfin (BMEYE B.V. Amsterdam, the Netherlands)
allows hemodynamic monitoring with both BP and CO
continuously available in patients without an arterial line.
Continuous BP is measured with a cuff around a finger and a
pulse contour method calculates beat-to-beat CO. This
review summarizes past and present developments in BP
and CO measurement with a focus on continuous nonin-
vasive finger cuff technology and its clinical applications.
2 Overview of methods for measurement of blood
pressure
The first quantitative measurements of blood pressure were
performed in animals by Hales in 1733 [24, 25]. Early reports
of intra-arterial pressure measurement in the human are from
1912, when Bleichro¨der [26] cannulated his own radial
artery. It is unlikely that he recorded his BP although it would
have been possible at that time: Frank developed accurate
and fast manometers that could measure pulsatile pressure in
1903 [27]. Invasive measurement of BP was confined to the
physiology labs for quite some time [28, 29]. However in the
1950s and 1960s, with the development of refined insertion
techniques [30] and Teflon catheters it became standard
clinical practice. High fidelity catheter-tip manometers, such
as used to measure pressure gradients across a coronary
stenosis, were introduced by Murgo and Millar in 1972 [31].
Table 1 gives an overview of BP methods.
Practical noninvasive (intermittent) BP measurement
became possible when Riva-Rocci presented his air-
inflatable arm cuff connected to a manometer in 1896 [32,
33]. By deflating the cuff and feeling for the pulse, systolic
BP could be determined. In 1905 Korotkoff [34, 35]
advanced the technique further with the auscultatory
method making it possible to determine diastolic pressure
as well. In 1903 Cushing recommended BP monitoring
using the Riva-Rocci sphygmomanometer for patients
under general anesthesia [36]. Nowadays, automated
assessment of BP with oscillometric devices is commonly
used. These devices determine BP by analyzing the
oscillations measured in the cuff-pressure. The pressure in
the cuff is first brought above systolic pressure and then
deflated to below diastolic pressure. Oscillations are largest
when cuff pressure equals mean arterial pressure. Pro-
prietary algorithms determine systolic and diastolic values
from the oscillations. Oscillometers may be inaccurate
[37], and provided values that are frequently lower than
direct BP measurements in critically ill patients, [38, 39]
whereas detection of large BP changes is unreliable [40].
Due to its intermittent nature hyper- and hypotensive
periods may be missed [2].
‘‘Semi-continuous noninvasive methods’’ based on
radial arterial tonometry require an additional arm cuff to
calibrate arterial pressure [41–43]. The use of these devices
may become problematic under conditions with significant
patient motion or surgical manipulation of the limbs [43,
44]. However, tonometry devices have contributed greatly
to the knowledge of the relation between the pressure wave
shape and cardiovascular function [45, 46].
3 Noninvasive continuous measurement of blood
pressure
Continuous noninvasive measurement of BP is possible
using finger cuff technology. The first generation using this
technology was introduced with the FinapresTM device
developed by Wesseling et al. [47] in the early 1980s. This
technology is based on the volume-clamp method invented
by the Czech physiologist Jan Penˇa´z [47–49]. The diameter
of a finger artery under a cuff is ‘‘clamped’’ i.e. kept at a
constant diameter in the presence of the changes in arterial
pressure during each heart beat. Changes in diameter are
measured by means of an infrared photo-plethysmograph
built into the finger cuff. The finger cuff keeps the diameter
of the underlying arteries constant by dynamically applying
a counter-pressure throughout the cardiac cycle. When, for
instance, during systole an increase in arterial volume is
detected by the plethysmograph, the cuff pressure is
immediately increased by a rapid pressure servo-controller
system to prevent the volume change [17]. An artery could
be clamped at any volume between collapsed and fully
extended, but in either case the vessel wall will bear part of
the pressure. Only when the artery is kept at its ‘‘unloaded’’
volume, there is no tension in the wall and internal pressure
equals external pressure. Defining the correct unloaded
volume of a finger artery is not straightforward. Moreover,
the unloaded volume of an artery has to be established
regularly since it is a function of arterial wall smooth
muscle stress and tone. At zero transmural pressure the
artery is not collapsed but retains approximately 1/3 or 1/2
of its maximal volume. The unloaded volume is also close
to the volume it would have at a mean pressure where the
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amplitude of the pulsations in the plethysmogram are
largest. The unloaded volume can be established by
‘‘Physiocal’’, developed by Wesseling et al. Physiocal
analyzes the curvature and sharpness of the plethysmogram
during short periods of steady cuff pressure levels [49]. A
set of criteria allows determining whether the volume is
precisely at a level that holds the optimum between the
slightly too much collapsed and slightly too much extended
volumes. The analysis is automatically repeated regularly
during measurement, to follow changing physiological
Table 1 Methods for measurement of blood pressure and cardiac output
System Method Company CO BP
Nexfin Finger cuff technology/pulse contour analysis BMEYE ? ___ ? ___
Finometer Finger cuff technology/pulse contour analysis FMS ? ___ ? ___
LIFEGARD ICG Thoracic electrical bioimpedance CAS Medical Systems, Inc. ? ___ ? …
BioZ Monitor Impedance cardiography CardioDynamics International
Corporation
? ___ ? …
Cheetah reliant ‘‘Bioreactance’’ Cheetah Medical ? ___ ? …




? ___ ? …
AESCULON Electrical ‘‘velocimetry’’ Osypka Medical GmbH ? ___ ? …
HIC-4000 Impedance cardiography Microtronics Corp Bio Imp Tech, Inc. ? ___
NICaS Regional impedance NImedical ? ___
IQ2 3-dimensional impedance Noninvasive Medical Technologies ? ___
ICON Electrical ‘‘velocimetry’’ Osypka Medical GmbH ? ___
PHYSIO FLOW Thoracic electrical bioimpedance Manatec biomedical ? ___
AcQtrac Thoracic impedance Va¨samed ? ___
esCCO Pulse wave transit time Nihon Kohden ? ___
TEBCO Thoracic electrical bioimpedance HEMO SAPIENS INC. ? ___
NCCOM 3 Impedance cardiography Bomed Medical Manufacturing Ltd ? ___
RheoCardioMonitor Impedance cardiography Rheo-Graphic PTE ? ___
HemoSonicTM 100 transesophageal Doppler Arrow Critical Care Products ? ___
ECOM Endotracheal bioimpedance ConMed Corporation ? ___
CardioQ-ODMTM Oesophageal Doppler Deltex ? ___
TECO Transesophageal Doppler Medicina ? ___
ODM II Transesophageal Doppler Abbott ? ___
HDI/PulseWaveTM CR-
2000
Pressure waveform analysis Hypertension Diagnostics, Inc ? _ _ ? _ _
USCOM 1A Transthoracic Doppler Uscom ? _ _
NICO Rebreathing Fick Philips Respironics ? …
Innocor Rebreathing Fick Innovision A/S ? …
Vigileo/FloTrac Pulse contour analysis Edwards Lifesciences – ___ – ___
LiDCOplus PulseCO Transpulmonary lithium dilution/pulse contour
analysis
LiDCO Ltd – ___ – ___
PiCCO2 Transpulmonary thermodilution/pulse contour
analysis
PULSION Medical Systems AG – ___ – ___
MOSTCARE PRAM Pulse contour analysis Vytech – ___ – ___
Vigilance Pulmonary artery catheter thermodilution Edwards Lifesciences – … – ___
DDG Dye-densitogram analyzer Nihon Kohden – …
Truccom Pulmonary artery catheter thermodilution Omega Critical Care – …
COstatus Ultrasound dilution Transonic Systems Inc. – ? …
CNAP Monitor 500 Finger cuff technology CNSystems Medizintechnik AG ? ___
SphygmoCor CPV
System
Applanation tonometry AtCor Medical ? _ _
TL-200 T-LINE Applanation tonometry Tensys Medical, Inc. ? _ _
? noninvasive, – invasive, ___ continuous, _ _ semi-continuous, … intermittent
J Clin Monit Comput (2012) 26:267–278 269
123
states of the vasculature. Owing to Physiocal, calibrated
recordings of the entire finger arterial pressure wave are
obtained [17]. Generally, an interval between Physiocal
calibrations of more than 30 beats is accepted as a criterion
for a reliable measurement. Pressure values are typically
available within approximately 1 min after starting the
measurement. While the Finapres and its successors use
Physiocal, the CNAP device (CNSystems Medizintechnik
AG, Graz, Austria) uses ‘interlocking control loops’ for
volume clamping called the VERIFI algorithm. However,
frequent calibration with an upper arm cuff is still needed
[50].
The Finapres device showed the arterial pressure as
measured at the finger. However, since the brachial site is
the clinical standard for noninvasive BP measurement later
devices such as the Finometer (FMS, Amsterdam, the
Netherlands) and the Nexfin (BMEYE, Amsterdam, the
Netherlands) show the brachial pressure reconstructed from
the finger pressure. Reconstruction reverses the physio-
logical waveform transformation that waves experience
while travelling through the arterial system (see Fig. 1).
The progressively narrowing arteries cause backwards
reflection of the pressure waves, resulting in a more peaked
waveform towards the periphery. Additionally, in the
smaller arteries, the resistance starts to play a role and
pressure levels become affected. The change in waveform
from the central to the peripheral arteries is largely pre-
dictable [51–53]. The waveform transformation along the
arm can be mathematically described and this description
can be used to reverse the transformation [54, 55]. The
pressure drop due to resistance to flow in the smaller
arteries can be compensated by application of a level
correction formula. This population based formula deter-
mines a pressure drop based on systolic and diastolic val-
ues [51]. The combination of these two methods
reconstructs brachial artery pressures from finger arterial
pressures. An alternative is used in the CNAP device that
displays a finger pressure wave that is fitted to systolic and
diastolic pressures from upper arm cuff measurements.
Both the Finometer and the Nexfin use a system that
automatically corrects for hydrostatic differences in pres-
sure when the hand is not at heart level. The ‘‘finger side’’
of the heart reference system is fixed next to the finger on
which the cuff is applied and the ‘‘heart side’’ at right atrial
level. The hydrostatic difference is measured and the
recordings are continuously corrected to give BP at heart
level. The CNAP device uses repeated upper arm cuff
measurements to compensate for hydrostatic pressure
differences.
4 Validation of noninvasive continuous measurement
of blood pressure
Tracking of changes in BP was already considered good in
earlier devices using the finger cuff technology [56]. With
the physiological waveform transformation absolute values
reconstructed from finger arterial pressures are comparable
with (non-) invasively measured brachial or radial pressures
[57–59]. Measurements with the Nexfin are performed
without the need for an external calibration whereas other
devices using finger cuff technology such as the Finometer
[17, 60] and the CNAP require extra measurements with an
upper arm cuff [61]. A recent overview of noninvasive BP
monitors and clinical validation studies focused specifically
on the need for calibration by a separate method [62].
The BP measurement with the latest generation finger
cuff technology device, the Nexfin, was validated against
both invasive and noninvasive methods [59, 63, 64]. From a
comparison against an auscultatory BP measurement (Riva-
Rocci/Korotkoff) in 104 subjects it was concluded that
Nexfin provides accurate measurement of BP with good
within-subject precision [59]. Validation against invasive
radial pressure was performed in fifty patients during coro-
nary artery bypass grafting [64]. Within-patient analyses
showed excellent correlations between the noninvasive and
invasive pressures and good within subject precisions over
wide ranges of pressure changes. Moreover, bias and
Fig. 1 The differences in
pressure levels and wave shape
in the radial (red) and finger
(blue) arteries. A physiological
model can reconstruct the
brachial artery pressure (green)
from the finger arterial pressure.
The staircase is the result of an
automatic calibration. (Color
figure online)
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precision, defined as group average and standard deviation
of the differences, were within AAMI criteria [65]. No
relation was found between the differences and mean arterial
pressure or HR, indicating that the reconstruction method-
ology performs well in a wide range of hemodynamic states.
It was concluded that noninvasively measured blood pres-
sure could follow changes in pressure and provided values
comparable to invasive monitoring.
The Nexfin has also been evaluated in an emergency
care setting where the authors concluded that continuous
BP and HR measured by the Nexfin device showed rea-
sonable agreement when compared with the intermittent
values obtained by automated ED equipment [66]. How-
ever, they also suggested that theoretically, noninvasive
and continuous monitoring of the BP and HR might better
reflect underlying hemodynamics than these same mea-
surements obtained intermittently and, thus, could be
important in patient management [66].
5 Overview of methods for measurement of cardiac
output
Various methods to measure CO are being used and can be
characterized by their invasiveness or their ability to
measure continuously. Table 1 gives an overview of CO
methods. One of the first methods to determine flow was
proposed by Fick [67], and uses the relation between the
rate of uptake of oxygen in an organ and the difference of
oxygen concentrations over that organ. Therefore, to
measure CO (total flow in the body), arterial and mixed
venous oxygen concentrations as well as oxygen con-
sumption need to be sampled. Frank, also known for the
Frank-Starling law of the heart, developed the 2-element
Windkessel model to determine CO [68]. The two elements
of this model are total arterial compliance and systemic
vascular resistance. After total arterial compliance was
estimated by a pulse wave velocity measurement, systemic
vascular resistance could be determined from the diastolic
decay of the pressure curve. Using Ohm’s law, CO could
then be calculated by dividing mean arterial pressure by
this resistance. This method can be seen as a very early
pulse contour method, in which the shape of the pressure
wave is analyzed to obtain CO.
Indicator dilution techniques use the Stewart-Hamilton
[69] equation to describe the rate at which an indicator,
injected into the blood stream, is diluted. CO is calculated
from the quantity of injected indicator and the area under
the Stewart-Hamilton curve measured downstream. The
indicator usually is a dye or a thermal marker, and is
injected into a vein and following passage through the heart
subsequently sampled from an artery. For the thermodilu-
tion technique iced glucose is injected in the right atrium
and the temperature downstream in the pulmonary artery is
sampled with the Swan-Ganz catheter [70]. To obtain a
reliable estimation with these techniques CO should remain
constant for at least the duration of a single measurement.
However, HR, SV and BP may change rapidly and this has
resulted in the practice to perform several estimations of
CO, and even sometimes in elimination of outliers from a
series of consecutive thermodilution estimates, both indi-
cating that the requirement of stability is usually not met.
Determination of CO with the thermodilution method is
in general restricted to the critically ill patients or patients
at high risk associated with an intervention or with serious
comorbidities. The use of intermittent estimation of CO by
thermodilution is decreasing [20–22] owing to the invasive
nature of pulmonary artery catheterization. Besides the
requirement to be less invasive, it may also be necessary to
measure hemodynamic changes with short time intervals.
Hereto, monitors need to provide a continuous measure of
CO, usually based on analysis of the arterial BP curve
(‘‘pulse contour’’ methods).
In their publication of 1904 Erlanger and Hooker
determined cardiac SV from characteristics of the arterial
pressure pulse [71]. Pulse contour methods are based on
solid physical principles, less solid physiological models,
and involve substantial computations [72]. Until recently,
pulse contour methods analyzed the arterial pulse wave
from an intra-arterial catheter, initially in place for BP
monitoring or sampling for blood gas analysis. Several
minimally invasive techniques have become available that
provide continuous CO measurement [73] operating either
with or without an additional (invasive, intermittent) cali-
bration. The LiDCO system applies a bolus indicator
dilution method for CO measurement using lithium chlo-
ride as an indicator. Detection of the indicator in arterial
blood through a lithium-sensitive electrode produces a
lithium concentration–time curve [19]. The produced CO
estimate is used to calibrate a pulse contour-derived SV.
The PiCCO system also utilizes pulse contour analysis of
intra-arterial BP for continuous CO monitoring, whereas
transpulmonary thermodilution is used for calibration [74].
Although still invasive to some extent an advantage of
these techniques over conventional thermodilution is that
pulmonary artery catheterization is not required. The Flo-
Trac/VigileoTM system also uses an intra-arterial pressure
waveform based pulse contour analysis [75–77], but
without the need to calibrate.
In general, calibration may improve the accuracy of the
absolute values, but is not essential as long as changes in
CO are accurately tracked. Continuous tracking is neces-
sary to assess the response to a relatively fast hemody-
namic change, such as a fluid challenge or passive leg-
raising. Responding to the challenge with a certain increase
in CO indicates that the patient is fluid responsive and thus
J Clin Monit Comput (2012) 26:267–278 271
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may benefit from receiving additional fluid [7, 9, 78]. A
recent meta-analysis comprehensively reviews current
minimally invasive CO techniques [79].
6 Noninvasive continuous measurement of cardiac
output
Noninvasive and (semi-)continuous tracking of changes in
SV can be accomplished by thoracic electrical impedance
[80–82], ultrasound [14, 83] and by pulse contour analysis
[84–88]. Pitfalls of the first method include electrode
placement, motion artifacts, validity of the applied equa-
tions, and calibration [89, 90]. Doppler ultrasound mea-
surement of aortic blood velocity combined with
echocardiographic estimation of the aortic root cross-sec-
tional area yields SV, although semi-continuous at best.
The application of the semi-invasive trans-esophageal
approach is limited to anesthetized patients. For a trans-
thoracic approach the Doppler probe has to be held over the
root of the aorta requiring a skilled operator and constancy
of probe angle to minimize bias [83]. Nonetheless,
esophageal Doppler has been shown to give positive results
in goal-directed therapy [91–93].
In order to determine beat-to-beat SV and CO from
noninvasive continuous BP from the finger a pulse contour
method based on a physiological model of the circulation is
used. In the early 1970s Wesseling developed the cZ pulse
contour method making use of the systolic part of the
pressure curve (pulsatile systolic area, PSA, see Fig. 2).
This cZ method used a constant impedance Z to calculate
the SV from the PSA. An empirical formula incorporating
patient age, HR and mean arterial pressure was used to
dynamically correct the impedance Z (hence the name cZ
for corrected impedance) for changes in the hemodynamic
status. Tracking of SV changes was reliable, but calibration
of Z with a reference method was necessary for correct
absolute values. Subsequent to the cZ method, Wesseling
et al. developed a method using a 3-element Windkessel
description of aortic input impedance. By adding a third
element to Frank’s 2-element Windkessel, Westerhof et al.
[94, 95] substantially improved the modeling of the pres-
sure-flow relation [96]. The third element, the character-
istic impedance Zc represents the impedance that the
ventricle encounters during ejection. Its value is deter-
mined by the interaction of the capacity of the proximal
aorta to store volume (thus proximal compliance C) and the
blood mass that needs to be accelerated (inertance L). Zc is
equal to the square root of L/C. Windkessel compliance Cw
is equal to the sum of the compliances of all arteries,
mainly the ascending and descending aorta, and it repre-
sents the ability to elastically store the stroke volume
ejected by the heart. Peripheral resistance Rp equals the
sum of all resistances of small arteries and arterioles,
representing the resistance to the flow of blood. In Wes-
seling’s Modelfow method a Windkessel model is used in
which Zc and Cw are nonlinear functions of pressure, age,
gender, height and weight [97] assuring better absolute CO
values and tracking over a wider range of pressures [98].
Using pressure as input a flow curve could be calculated
[18, 99, 100]. Subsequent integration of the flow curve
yielded SV.
Nexfin CO-trek is a model implemented in the Nexfin
that calculates beat-to-beat SV by dividing the area under
the systolic part of the reconstructed brachial artery pressure
curve by the aortic input impedance (Zin, Fig. 2). Zin is
determined from a 3-element Windkessel model [94, 96]
with nonlinear descriptions for the parameters as proposed
by Wesseling. Values for SV become instantaneously
available with the onset of the BP measurement. Using the
described physiological models for pressure reconstruction
and input impedance, Nexfin CO-trek was internally eval-
uated on data including invasive and noninvasive finger
arterial pressures together with thermodilution CO data
obtained during cardiac surgery [98, 99], from healthy
subjects experiencing progressive central hypovolemia
induced by passive head-up tilt [15], and from critically-ill
patients with arterial hypotension due to severe septic shock
and treated with catecholamines [16]. Thermodilution CO
in these trials was determined with quadruple respiratory
phase controlled thermodilution estimates [101]. A specific
objective for the development of Nexfin CO-trek was that
noninvasive arterial pressure should be employed as input.
7 Validation of noninvasive continuous measurement
of cardiac output
Thoracic electrical impedance and ultrasound measurement
of CO have been extensively described in the literature.
Raaijmakers concluded that ‘‘impedance CO might be
useful for trend analysis’’ [102]. Coats concluded that
‘‘Doppler methods are safe, fairly reproducible and rea-
sonably accurate’’ [103]. It should be noted that, although
ultrasound is often used to assess fluid responsiveness, the
change in aortic diameter may give rise to substantial errors
when not accounted for [104].
In a recent study both noninvasive finger arterial pres-
sure and intra-arterial pressure input were used as input to
two validate methods: Nexfin CO-trek and Modelflow.
Awake post-coronary artery bypass surgery patients with a
pulmonary artery thermodilution-based estimate of CO
serving as a reference were included [58]. Measurements
were done with patients in supine and sitting position. It
was found that Nexfin CO-trek readings were comparable
to thermodilution CO, with intra-arterial pressure as well as
272 J Clin Monit Comput (2012) 26:267–278
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with noninvasive finger arterial pressure as input. The
earlier Modelflow CO-method, developed to be used with
invasively measured pressures, performed less well on
noninvasive measured BP [58].
Sokolski et al. examined 25 ICU patients with advanced
heart failure to compare CO measurements using the pul-
monary artery catheter thermodilution method and using
the Nexfin [105]. The reported bias and standard deviation
were 0.1 and 0.4 l/min, respectively. These results are
promising, especially considering the fact that the popu-
lation included 13 patients with atrial fibrillation and 13
patients with decompensated heart failure. The authors
therefore conclude that the Nexfin could be applied in
clinical practice for patients with advanced HF.
Broch et al. concluded that ‘‘the Nexfin is a reliable
method of measuring cardiac output during and after car-
diac surgery’’ [106]. Compared with trans-cardiopulmo-
nary thermodilution, the mean bias of Nexfin was -0.1
(95 % limits of agreement -0.6 to ?0.5, percentage error
23 %) and -0.1 (-0.8 to ?0.6, 26 %) l min-1 m-2, before
and after cardiopulmonary bypass, respectively. These data
show that Nexfin gives excellent results without calibra-
tion. Further, a good correlation between the two methods
was found when passive leg-raise was performed, with
R2 = 0.72, p \ 0.001 before and R2 = 0.76, p \ 0.001
after cardiopulmonary bypass.
Two recent studies further demonstrated the ability of
tracking changes in CO. The first compared the changes
in SV measured by Nexfin CO-trek with the echo
Doppler aortic velocity–time integral as a measure of SV
Fig. 2 The cZ pulse contour method, Modelflow and Nexfin CO-trek.
The corrected Z (‘‘cZ’’, top) method uses an impedance Z to calculate
stroke volume (SV) [121]. The time-integral of the arterial pressure
wave above diastolic pressure and between valve opening and closing
(as determined by upstroke and incisura) is called the pulsatile
systolic area (PSA, hashed area in the Figure) of the pressure. This
PSA together with the characteristic impedance Zc, which is estimated
from age and depending on mean arterial pressure (MAP) and heart
rate (HR, the inverse of the heart period of the pressure wave), gives
SV. Cardiac output (CO) is calculated by multiplying SV and HR.
The method was developed for tracking of changes in CO and for
correct absolute values a calibration of Z was necessary. In the
Modelflow method (middle) the 3-element Windkessel was imple-
mented. Zc and Windkessel compliance Cw depend on age, gender,
height and weight and are nonlinearly related to pressure as shown in
the pressure—area relation [97]. Thus, patient data and arterial
pressures are both needed to determine these Windkessel parameters
[99]. The time varying Rp is the ratio of MAP and CO and iteratively
determined. To calculate CO, Modelflow imposes arterial pressure on
the Windkessel model. A flow curve is produced of which the time-
integral gives SV. The Nexfin CO-trek method (bottom) divides the
PSA by the input impedance of the Windkessel to instantaneously
give SV. In contrast to Modelflow, there is no need for constructing a
flow curve. Moreover while Modelflow was developed to be used on
invasive pressures, Nexfin CO-trek was developed to work with
noninvasive BP as measured with Nexfin [58].
b
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during the optimization of atrioventricular delay in car-
diac resynchronization therapy and a good agreement was
found [107]. The second study compared, during exer-
cise, the CO of Nexfin CO-trek with inert gas rebreathing
method for CO estimation [108]. A good correlation was
found and values actually converged for large CO values
[109].
8 Clinical applications of noninvasive continuous
hemodynamic monitoring
8.1 Anesthesiology
Continuous, totally noninvasive monitoring is possible in
groups currently (nearly) unmonitored. Examples include
orthopedic surgery in the elderly, abdominal surgery and
bariatric surgery. In obese patients upper arm cuffs for BP
measurement often do not fit, and thigh cuffs are needed, or
a brachial cuff is used on the forearm. While the arms and
legs can increase significantly in circumference, fingers do
get larger but usually not up to the degree that the finger
cuff does not fit.
For surgical patients volume treatment corrects a peri-
operative volume deficit and attenuates negative influences
on the central blood volume (corresponding to the diastolic
volume of the heart) caused by, e.g. hemorrhage, reposi-
tioning of the patient, anesthesia and ventilation. Inter-
pretation of the heart rate (HR) and arterial pressure
responses to a reduced central blood volume is complex.
Cardiovascular variables are regulated and affected by
influences other than central blood volume, including sur-
gical stress and anesthesia [10]. This makes it unlikely that
accurate volume treatment can be based on HR and BP
alone. Considering the important contribution of a sub-
normal central blood volume in circulatory shock, a defi-
nition of normovolemia may be derived from
individualized goal-directed volume therapy, not only to
the patient in shock but also to patients in the perioperative
period [8]. Cerebral blood flow and oxygenation become
affected with a blood loss corresponding to 30 % of the
central blood volume [110] or a blood loss of 1.0–1.5 l [9].
It is becoming clear that monitoring of the circulation
allows for intervention well before cerebral blood flow and
oxygenation become affected [111]. Fluid therapy guided
by cardiac output has been demonstrated to improve peri-
operative outcome and reduce complications and the length
of hospital stay [91, 92, 112]. This goal-directed volume
treatment is guided by various techniques that determine
cardiac output [92, 93]. The availability of noninvasive and
continuous monitoring of SV or CO enables individuali-
zation of fluid treatment from fixed-volume to goal-direc-
ted volume therapy in a wide range of patients.
8.2 Emergency care
Noninvasiveness and ability for quick assessment allows
the characterization of hemodynamic profiles of patients in
the Emergency Department and following of possible
changes. It was demonstrated by Nowak et al. [113] that
emergency physicians, when asked whether the CO of their
patients was low, normal or high, were right only half of the
time. Nonetheless decisions in acutely ill patients are based
on such assumptions of the underlying hemodynamic pro-
file [113] with potentially important clinical ramifications.
8.3 Cardiology
In cardiac resynchronization therapy, the atrioventricular
delay or the inter-ventricular delay can be chosen to opti-
mize SV. In a study comparing noninvasive pulse contour
SV with echo Doppler aortic velocity–time integral while
optimizing the atrioventricular delay, a good agreement
was found and the authors concluded that Nexfin is a
promising tool in individual optimization [107].
During invasive electrophysiology procedures, it is
common practice to use an intra-arterial line to monitor BP
in critical situations of hypotension caused by tachyar-
rhythmias or by intermittent incremental ventricular tem-
porary pacing till to the maximally tolerated systolic BP
fall. During such procedures Nexfin recorded reliable BP
waveforms notwithstanding the presence of tachyarrhyth-
mia [114]. The authors stated that continuous noninvasive
BP monitoring is feasible in the interventional electro-
physiology laboratory and may replace intra-arterial BP in
that setting.
Noninvasive BP with finger cuff technology has been
used for a long time in the diagnosis and management of
syncope [115] and is used in tilt table testing and other
autonomic function testing [116]. Nexfin enables continu-
ous cardiovascular evaluation of patients presenting with
unexplained syncopal attacks and thus considerably con-
tributed to diagnostic efficacy and accuracy [117]. Also in
this field CO is receiving increasing attention [118].
9 Conclusion and perspective
As indicated by De Waal et al. [119] the ideal CO monitor
should be: ‘‘reliable, continuous, noninvasive, operator-
independent, cost-effective, and should have a fast
response time (beat-to-beat).’’ Noninvasive and continuous
determination of CO with the Nexfin is comparable to
thermodilution CO, is continuous, truly noninvasive and
operator independent. Generally within a minute after start-
up, beat-to-beat data on BP, HR, SV and CO become
simultaneously available. The only point of contact with
274 J Clin Monit Comput (2012) 26:267–278
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the patient is the cuff around a finger. CO monitoring is not
routine practice yet due to its often invasive and intermit-
tent nature. Nonetheless, fluid therapy guided by CO has
been shown to improve perioperative outcome and to
reduce complications as well as length of hospital stay
[112, 120]. Noninvasive continuous CO techniques make
routine monitoring of CO readily available facilitating
easier assessment of fluid-responsiveness and a further
application of goal directed fluid therapy.
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